Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

Thymosin beta 4 protects cells from damage by blocking a harmful microRNA and boosting a protective gene.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

TNF-alpha inhibitors can cause various immune-related skin issues.

Blocking IL-8 can reduce skin rashes from cancer treatment.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Blocking mTORC1 may help prevent skin cancer by stopping the growth of certain skin stem cells.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

ATR04-484 ointment shows promise for treating skin issues from cancer therapies.

Blocking certain proteins on immune cells may help treat alopecia areata.

Lipid-antigen stimulation may play a role in folliculotropic mycosis fungoides.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

Antibody treatments show promise for hair loss but need more research.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Researchers found a specific T cell receptor linked to severe drug reactions like Stevens-Johnson syndrome when patients take carbamazepine.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

The system allows precise control of gene expression in mouse skin, useful for studying skin biology.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.